The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 11, 2012
Filed:
May. 17, 2007
Andrey Alexandrovich Ivashchenko, Moscow, RU;
Sergey Yevgenievich Tkachenko, San Diego, CA (US);
Alexander Viktorovich Khvat, San Diego, CA (US);
Oleg Dmitrievich Mitkin, Khimki, RU;
Ilya Matusovich Okun, San Diego, CA (US);
Alexandr Sergeevich Kyselvev, San Diego, CA (US);
Volodymyr Mikhailovich Kysil, Kiev, UA;
Nikolay Filippovich Savchuk, Rancho Santa Fe, CA (US);
Alexander Vasilievich Ivachtchenko, Encinitas, CA (US);
Andrey Alexandrovich Ivashchenko, Moscow, RU;
Sergey Yevgenievich Tkachenko, San Diego, CA (US);
Alexander Viktorovich Khvat, San Diego, CA (US);
Oleg Dmitrievich Mitkin, Khimki, RU;
Ilya Matusovich Okun, San Diego, CA (US);
Alexandr Sergeevich Kyselvev, San Diego, CA (US);
Volodymyr Mikhailovich Kysil, Kiev, UA;
Nikolay Filippovich Savchuk, Rancho Santa Fe, CA (US);
Alexander Vasilievich Ivachtchenko, Encinitas, CA (US);
Other;
Abstract
The invention relates to novel substituted indoles, to the use thereof in the form of pharmacological composition substances and to use of said composition for producing medicinal preparations used for preventing and treating viral diseases, in particular caused by viruses of infectious hepatitis (HCV, HBV), human immune deficiency (HIV), atypical pneumonia (SARS) and bird flu. The invention proposes novel substituted indoles of general formula (1) or the racemates or the optical isomers or the pharmaceutically acceptable salts and/or hydrates thereof, wherein R, Rand Rindependently of each other are an aminogroup substituent selected for hydrogen, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted aryl or optionally substituted heterocyclyl, or Rand Rtogether with a nitrogen atom, with which they are bound, form through Rand Roptionally substituted azaheterocyclyl or guanidyl; Ris analkyl substituent selected from hydrogen, an optionally substituted mercaptogroup, optionally substituted aminogroup and optionally substituted hydroxyl; Ris lower alkyl, Ris an hydrogen atom or Rtogether with an oxygen atom with which it is linked or Rtogether with a nitrogen atom with which it is linked close, via Rand Ran oxazine cycle; Ris a cyclic system substituent selected for hydrogen, a halogen atom, cyanogroup, optionally substituted aryl or substituted heterocyclyl.